OM PHARMA in direct marketing and sales operations across the Gulf countries
September 5th, 2007

OM PHARMA has set up direct sales operations in the Gulf countries to expand the marketing of Broncho-Vaxom ®, Dicynone ®, Doxium ®, Uro-Vaxom ® and Doxiproct ® in the United Arab Emirates, Oman, Bahrain, Qatar and Kuwait. The Regional Manager has direct responsibility across the five countries with supervision of the sales teams and reports to OM PHARMA’s headquarters in Meyrin/Geneva. The size of this market reaches 1.6 million CHF ex-Geneva for OM PHARMA’s business portfolio.

Top of the page